Analysis published 07 Apr 2026

AI-generated · cited to primary sources · not investment advice

Acutaas Chemical (543349) Oct 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

ExceededOther Findings
94/100

Working capital efficiency has improved significantly to 100 days in Q2, better than the 110-day target, with management now guiding for 95-105 days. (3 exceeded, 2 met across 5 tracked commitments)

To conclude, our business continues to stand on a strong and resilient foundation, well positioned to deliver around 25% revenue growth for the year.

Acutaas Chemical · Concall Transcript · Oct 2025 · p.4
Shift to Complex and Specialty Generics

Production for the battery chemical business is expected to commence in Q4 FY26. — target: Commence production (+1 more commitment)

In our battery chemical business, we have successfully secured multiple customers across diverse geographies. Production is expected to commence in Q4 FY '26 once our ongoing capex is completed.

Acutaas Chemical · Concall Transcript · Oct 2025 · p.4

See the full cited Management analysis of Acutaas Chemical

Create free account →
02 · Business Model

How durable is the business?

API Backward Integration Advantage
80/100

Profitability has significantly expanded due to a better product mix (churning out low-margin products) and operational efficiencies, including a new solar power plant. (4 expanding)

EBITDA margins were at 31.1%, up 1,130 basis points Y-o-Y. EBITDA margin was driven by expansion in gross margin as well as operating leverage.

Acutaas Chemical · Concall Transcript · Oct 2025 · p.6

See the full cited Business Model analysis of Acutaas Chemical

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.